Suppr超能文献

(1,5)-2,2-二甲氧基双环[3.1.0]己烷-3-酮的可扩展合成路线的开发:来那卡韦合成中的重要中间体

Development of a Scalable Synthetic Route to (1,5)-2,2-Dimethoxybicyclo[3.1.0]hexan-3-one: An Important Intermediate in the Synthesis of Lenacapavir.

作者信息

Nunes De Souza Aline, Sakkani Nagaraju, Guthrie Daryl, Sahani Rajkumar Lalji, Saathoff John M, Hochstetler Samuel R, Burns Justina M, Ahmad Saeed, Laidlaw G Michael, Gupton B Frank, Klumpp Douglas A, Jin Limei

机构信息

Medicines for All Institute, Virginia Commonwealth University, Richmond, Virginia, 23284-3068, United States.

出版信息

Org Process Res Dev. 2025 Feb 26;29(3):846-855. doi: 10.1021/acs.oprd.4c00527. eCollection 2025 Mar 21.

Abstract

(1,5)-2,2-Dimethoxybicyclo[3.1.0]hexan-3-one is used in the asymmetric synthesis of lenacapavir. Herein, we report an enantioselective synthesis of this important chiral intermediate from the inexpensive commodity ()-epichlorohydrin. This synthetic method comprises 6 steps, including a 4-step telescoped bicyclic ketone synthesis, I-promoted hydroxylation, and an Albright-Goldman oxidation. This sequence affords (1,5)-2,2-dimethoxybicyclo[3.1.0]hexan-3-one in an overall 25% isolated yield as an enantiomerically pure compound. The entire process has been successfully demonstrated on a hundred-gram scale.

摘要

(1,5)-2,2-二甲氧基双环[3.1.0]己烷-3-酮用于来那卡韦的不对称合成。在此,我们报道了一种从廉价的商品()-环氧氯丙烷对这种重要手性中间体进行对映选择性合成的方法。该合成方法包括6步,其中有4步串联的双环酮合成、碘促进的羟基化反应以及奥尔布赖特-戈德曼氧化反应。该反应序列以对映体纯化合物的形式,以25%的总分离产率得到(1,5)-2,2-二甲氧基双环[3.1.0]己烷-3-酮。整个过程已在百克规模上成功得到验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e49/11934127/97c967f27fa3/op4c00527_0001.jpg

相似文献

1
Development of a Scalable Synthetic Route to (1,5)-2,2-Dimethoxybicyclo[3.1.0]hexan-3-one: An Important Intermediate in the Synthesis of Lenacapavir.
Org Process Res Dev. 2025 Feb 26;29(3):846-855. doi: 10.1021/acs.oprd.4c00527. eCollection 2025 Mar 21.
2
6
Design, Synthesis, and Application of Chiral Bicyclic Imidazole Catalysts.
Acc Chem Res. 2022 Sep 20;55(18):2708-2727. doi: 10.1021/acs.accounts.2c00455. Epub 2022 Aug 31.
7
A New Synthesis of Enantiopure Amine Fragment: An Important Intermediate to the Anti-HIV Drug Lenacapavir.
J Org Chem. 2025 Jan 10;90(1):471-478. doi: 10.1021/acs.joc.4c02380. Epub 2024 Dec 16.
8
High-Yield Synthesis of Enantiopure 1,2-Amino Alcohols from l-Phenylalanine via Linear and Divergent Enzymatic Cascades.
Org Process Res Dev. 2022 Jul 15;26(7):2085-2095. doi: 10.1021/acs.oprd.1c00490. Epub 2022 Mar 28.

本文引用的文献

1
A New Synthesis of Enantiopure Amine Fragment: An Important Intermediate to the Anti-HIV Drug Lenacapavir.
J Org Chem. 2025 Jan 10;90(1):471-478. doi: 10.1021/acs.joc.4c02380. Epub 2024 Dec 16.
2
Synthetic Process Development of ()-(+)-1,2-Epoxy-5-hexene: An Important Chiral Building Block.
Org Process Res Dev. 2024 Aug 1;28(8):3197-3205. doi: 10.1021/acs.oprd.4c00101. eCollection 2024 Aug 16.
3
4
Preparation of a Key Intermediate En Route to the Anti-HIV Drug Lenacapavir.
J Org Chem. 2024 Mar 15;89(6):3995-4000. doi: 10.1021/acs.joc.3c02855. Epub 2024 Mar 6.
5
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
N Engl J Med. 2022 May 12;386(19):1793-1803. doi: 10.1056/NEJMoa2115542.
6
Rotten to the core: antivirals targeting the HIV-1 capsid core.
Retrovirology. 2021 Dec 22;18(1):41. doi: 10.1186/s12977-021-00583-z.
7
Lenacapavir: a first-in-class HIV-1 capsid inhibitor.
Curr Opin HIV AIDS. 2022 Jan 1;17(1):15-21. doi: 10.1097/COH.0000000000000713.
8
An insight on medicinal aspects of novel HIV-1 capsid protein inhibitors.
Eur J Med Chem. 2021 May 5;217:113380. doi: 10.1016/j.ejmech.2021.113380. Epub 2021 Mar 15.
9
Structural and mechanistic bases for a potent HIV-1 capsid inhibitor.
Science. 2020 Oct 16;370(6514):360-364. doi: 10.1126/science.abb4808.
10
Clinical targeting of HIV capsid protein with a long-acting small molecule.
Nature. 2020 Aug;584(7822):614-618. doi: 10.1038/s41586-020-2443-1. Epub 2020 Jul 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验